Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Feb 1;21(2):128-144.
doi: 10.1093/ijnp/pyx081.

Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual Patient

Affiliations
Review

Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual Patient

Oloruntoba J Oluboka et al. Int J Neuropsychopharmacol. .

Abstract

Major depressive disorder is an often chronic and recurring illness. Left untreated, major depressive disorder may result in progressive alterations in brain morphometry and circuit function. Recent findings, however, suggest that pharmacotherapy may halt and possibly reverse those effects. These findings, together with evidence that a delay in treatment is associated with poorer clinical outcomes, underscore the urgency of rapidly treating depression to full recovery. Early optimized treatment, using measurement-based care and customizing treatment to the individual patient, may afford the best possible outcomes for each patient. The aim of this article is to present recommendations for using a patient-centered approach to rapidly provide optimal pharmacological treatment to patients with major depressive disorder. Offering major depressive disorder treatment determined by individual patient characteristics (e.g., predominant symptoms, medical history, comorbidities), patient preferences and expectations, and, critically, their own definition of wellness provides the best opportunity for full functional recovery.

Keywords: depression; function; pharmacotherapy; treatment optimization.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Early optimized treatment is critical to bringing patients to full symptomatic and functional recovery. From (Habert et al., 2016).

References

    1. Altamura AC, Serati M, Buoli M(2015)Is duration of illness really influencing outcome in major psychoses?Nord J Psychiatry 69:1–15. - PubMed
    1. American Academy of Professional Coders (2013)ICD-10 resource: coding for major depressive disorder http://cloud.aapc.com/documents/Depressive-Disorder-ICD-10-BH.pdf.
    1. American Psychiatric Association (2013)Major depressive disorder. In: Diagnostic and statistical manual of mental disorders (DSM-5), 5th ed, pp160–168. Washington, DC: American Psychiatric Association.
    1. Anderson IM, Ferrier IN, Baldwin RC, Cowen PJ, Howard L, Lewis G, Matthews K, McAllister-Williams RH, Peveler RC, Scott J, Tylee A(2008)Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol 22:343–396. - PubMed
    1. Andrade C.(2015)Bioequivalence of generic drugs. J Clin Psychiatry 76:e1130–1131. - PubMed

Publication types

MeSH terms

Substances